Moreover, we screened and validated these genes by qRT‐PCR and identified five potential effectors that may mediate the oncogenic effects of RIOK1 in HCC, namely PMS1, SPDL1, RAD18, BARD1, and SMARCA5 (Figure 6A). The gene discussed is BARD1; the disease is hepatocellular carcinoma.